Funds and ETFs Nanosonics Limited

Equities

NAN

AU000000NAN9

Advanced Medical Equipment & Technology

Delayed Australian S.E. 12:24:19 2024-04-29 am EDT 5-day change 1st Jan Change
2.895 AUD +5.27% Intraday chart for Nanosonics Limited +3.20% -34.09%

ETFs positioned on Nanosonics Limited

Name Weight AuM 1st Jan change Investor Rating
0.01% 773 M€ -.--% -
0.00% 10 M€ -3.35% -
0.00% 34 M€ +2.14% -
Nanosonics Limited is an Australia-based infection prevention company. The Company's principal activities include the manufacturing and distribution of the trophon ultrasound probe disinfector and its associated consumables and accessories. It is focused on the research, development, and commercialization of infection control and decontamination products and related technologies. Trophon technology includes high-frequency ultrasonic vibrations that generate a sonically activated hydrogen peroxide (H2O2) mist that kills bacteria, fungi, and viruses. Its products include trophon2, Nanosonics Auditpro, and trophon electron paramagnetic resonance (EPR). The Company’s trophon2 includes AcuTrace radio frequency identification (RFID) technology, which enables digital record keeping and captures disinfection data. Nanosonics Auditpro provides real-time intelligence on ultrasound probes, operators, and infection control events to manage infection prevention practices across organizations.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
12
Last Close Price
2.75 AUD
Average target price
3.204 AUD
Spread / Average Target
+16.52%
Consensus
  1. Stock Market
  2. Equities
  3. NAN Stock
  4. Funds and ETFs Nanosonics Limited